Literature DB >> 8597522

Serotonin and thermoregulation. Physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects.

P J Schwartz1, T A Wehr, N E Rosenthal, J J Bartko, D A Oren, C Luetke, D L Murphy.   

Abstract

Meta-chlorophenylpiperazine (m-CPP), a probe of central serotonergic function, elevates core temperature in rodents, nonhuman primates, and humans via serotonin receptor-mediated mechanisms. To further characterize the thermoregulatory aspects of this response, we studied 16 healthy volunteers using multiple core and skin temperature recording sites. Compared to placebo, intravenous m-CPP (0.08 mg/kg) produced statistically significant biphasic changes in rectal temperature, characterized by initial hypothermia (-0.04 degrees C at 12 minutes) followed by progressive hyperthermia (+0.17 degrees C at 90 minutes). m-CPP also produced significant increases in plasma norepinephrine concentrations. Analysis of the skin temperature recordings suggests that the effector mechanism primarily responsible for m-CPP-induced core hyperthermia is increased metabolic thermogenesis. Individual differences in the magnitude of the hyperthermia were independent of m-CPP plasma concentrations but were found to be linearly correlated with the level of the previous night's core rectal temperature minimum and mean. It appears that m-CPP activates a mode of metabolic thermogenesis governed by a nocturnally sensitive proportional control mechanism. The operation of such a proportional controller is characterized by a set point and a gain, and has been implicated in the general economy of mammalian energy balance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8597522     DOI: 10.1016/0893-133X(95)00026-A

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  10 in total

1.  Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.

Authors:  J Benjamin; B D Greenberg; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.

Authors:  Michael J Seminerio; Matthew J Robson; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2012-07-20       Impact factor: 4.432

3.  Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.

Authors:  Michael J Seminerio; Nidhi Kaushal; Jamaluddin Shaikh; Jason D Huber; Andrew Coop; Rae R Matsumoto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-02       Impact factor: 3.533

4.  Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.

Authors:  P Mazzola-Pomietto; C S Aulakh; K M Wozniak; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

5.  A positive relationship between ambient temperature and bipolar disorder identified using a national cohort of psychiatric inpatients.

Authors:  Tzu-I Sung; Mu-Jean Chen; Huey-Jen Su
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-07-05       Impact factor: 4.328

Review 6.  Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia.

Authors:  Rae R Matsumoto; Michael J Seminerio; Ryan C Turner; Matthew J Robson; Linda Nguyen; Diane B Miller; James P O'Callaghan
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

7.  An unusual case of hypothermia associated with therapeutic doses of olanzapine: a case report.

Authors:  Lalith Rmr Rasnayake; Harith Wimalarathne; Runkman Ktdp Jayapala; Chaminda Dm Gamage; Dinesh Lb Dassanayake; Shiroma L Ratnayake; Anuradha Colombage; Damith Nandadeva; Amitha Npk Nelumdeniya
Journal:  J Med Case Rep       Date:  2011-05-18

8.  ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia.

Authors:  F Noël; J B Nascimento-Viana; L A S Romeiro; R O Silva; L F N Lemes; A S Oliveira; T B S Giorno; P D Fernandes; C L M Silva
Journal:  Braz J Med Biol Res       Date:  2016       Impact factor: 2.590

9.  Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination.

Authors:  Sami Ben Hamida; Erin Plute; Sonia Bach; Christine Lazarus; Antoine Tracqui; Christian Kelche; Anne Pereira de Vasconcelos; Byron C Jones; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2007-03-08       Impact factor: 4.415

10.  Sasa Quelpaertensis Nakai Induced Antidepressant-Like Effect in Ovariectomized Rats.

Authors:  Noof Abdullah Shaif; Donghyun Cho; Daehyuk Jang; Hyung Min Kim; Jin-Oh Chung; Sunmi Kim; Dae Bang Seo; Kyu-Ri Kim; Jaekyoon Shin; Insop Shim
Journal:  Biomed Res Int       Date:  2019-07-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.